NewAmsterdam Pharma (NAMS) Operating Leases (2021 - 2025)
NewAmsterdam Pharma (NAMS) reported Operating Leases of $66000.0 for Q4 2025, down 67.33% on a YoY basis from $202000.0 in Q4 2024, and down 22.35% sequentially from $85000.0 in Q3 2025.
NewAmsterdam Pharma (NAMS) Operating Leases (2021 - 2025) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 5 years of Operating Leases data on file, last reported at $66000.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases fell 67.33% year-over-year to $66000.0; the trailing twelve-month figure through Dec 2025 stood at $66000.0 (down 67.33% YoY), and the FY2025 full-year result was $66000.0, down 67.33% from the prior year.
- Operating Leases declined to $66000.0 in Q4 2025, from $85000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $328000.0 in Q2 2024 to a low of $57133.9 in Q4 2022.
- A 5-year average of $144080.6 and a median of $114990.4 in 2021 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases soared 370.65% in 2024 and plunged 68.6% in 2025, its largest moves.
- Tracing NAMS's Operating Leases over 5 years: stood at $126980.8 in 2021, then sank by 55.01% to $57133.9 in 2022, then advanced by 21.98% to $69691.2 in 2023, then soared by 189.85% to $202000.0 in 2024, then slumped by 67.33% to $66000.0 in 2025.
- Business Quant data shows NAMS's Operating Leases at $66000.0 in Q4 2025, $85000.0 in Q3 2025, and $103000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | NewAmsterdam Pharma | 3.72 Bn | 3.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Dec 31, 2024 | 202,000.00 |
| Sep 30, 2024 | 266,000.00 |
| Jun 30, 2024 | 328,000.00 |
| Jun 30, 2023 | 69,691.16 |
| Dec 31, 2022 | 57,133.85 |
| Dec 31, 2021 | 126,980.78 |